Arginase Deficiency Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: ADF54B7EDC04EN
Market Monitor Global

Abstracts

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.

This report contains market size and forecasts of Arginase Deficiency Treatment in Global, including the following market information:

Global Arginase Deficiency Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Arginase Deficiency Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Arginase Deficiency Treatment include Helsinn Healthcare, Novartis Pharmaceuticals, Horizo??n Pharma and Medicis Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Arginase Deficiency Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Arginase Deficiency Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Arginase Deficiency Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Arginase Deficiency Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Arginase Deficiency Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drugs Stores
• Other

Global Arginase Deficiency Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Arginase Deficiency Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Arginase Deficiency Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Arginase Deficiency Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Helsinn Healthcare
• Novartis Pharmaceuticals
• Horizo??n Pharma
• Medicis Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Arginase Deficiency Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Arginase Deficiency Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ARGINASE DEFICIENCY TREATMENT OVERALL MARKET SIZE

2.1 Global Arginase Deficiency Treatment Market Size: 2021 VS 2028
2.2 Global Arginase Deficiency Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Arginase Deficiency Treatment Players in Global Market
3.2 Top Global Arginase Deficiency Treatment Companies Ranked by Revenue
3.3 Global Arginase Deficiency Treatment Revenue by Companies
3.4 Top 3 and Top 5 Arginase Deficiency Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Arginase Deficiency Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Arginase Deficiency Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Arginase Deficiency Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Arginase Deficiency Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Arginase Deficiency Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Arginase Deficiency Treatment Revenue & Forecasts
  4.2.1 By Type - Global Arginase Deficiency Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Arginase Deficiency Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Arginase Deficiency Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drugs Stores
  5.1.4 Other
5.2 By Application - Global Arginase Deficiency Treatment Revenue & Forecasts
  5.2.1 By Application - Global Arginase Deficiency Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Arginase Deficiency Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Arginase Deficiency Treatment Market Size, 2021 & 2028
6.2 By Region - Global Arginase Deficiency Treatment Revenue & Forecasts
  6.2.1 By Region - Global Arginase Deficiency Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Arginase Deficiency Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Arginase Deficiency Treatment Revenue, 2017-2028
  6.3.2 US Arginase Deficiency Treatment Market Size, 2017-2028
  6.3.3 Canada Arginase Deficiency Treatment Market Size, 2017-2028
  6.3.4 Mexico Arginase Deficiency Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Arginase Deficiency Treatment Revenue, 2017-2028
  6.4.2 Germany Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.3 France Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.4 U.K. Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.5 Italy Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.6 Russia Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Arginase Deficiency Treatment Market Size, 2017-2028
  6.4.8 Benelux Arginase Deficiency Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Arginase Deficiency Treatment Revenue, 2017-2028
  6.5.2 China Arginase Deficiency Treatment Market Size, 2017-2028
  6.5.3 Japan Arginase Deficiency Treatment Market Size, 2017-2028
  6.5.4 South Korea Arginase Deficiency Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Arginase Deficiency Treatment Market Size, 2017-2028
  6.5.6 India Arginase Deficiency Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Arginase Deficiency Treatment Revenue, 2017-2028
  6.6.2 Brazil Arginase Deficiency Treatment Market Size, 2017-2028
  6.6.3 Argentina Arginase Deficiency Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Arginase Deficiency Treatment Revenue, 2017-2028
  6.7.2 Turkey Arginase Deficiency Treatment Market Size, 2017-2028
  6.7.3 Israel Arginase Deficiency Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Arginase Deficiency Treatment Market Size, 2017-2028
  6.7.5 UAE Arginase Deficiency Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Helsinn Healthcare
  7.1.1 Helsinn Healthcare Corporate Summary
  7.1.2 Helsinn Healthcare Business Overview
  7.1.3 Helsinn Healthcare Arginase Deficiency Treatment Major Product Offerings
  7.1.4 Helsinn Healthcare Arginase Deficiency Treatment Revenue in Global Market (2017-2022)
  7.1.5 Helsinn Healthcare Key News
7.2 Novartis Pharmaceuticals
  7.2.1 Novartis Pharmaceuticals Corporate Summary
  7.2.2 Novartis Pharmaceuticals Business Overview
  7.2.3 Novartis Pharmaceuticals Arginase Deficiency Treatment Major Product Offerings
  7.2.4 Novartis Pharmaceuticals Arginase Deficiency Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Pharmaceuticals Key News
7.3 Horizo??n Pharma
  7.3.1 Horizo??n Pharma Corporate Summary
  7.3.2 Horizo??n Pharma Business Overview
  7.3.3 Horizo??n Pharma Arginase Deficiency Treatment Major Product Offerings
  7.3.4 Horizo??n Pharma Arginase Deficiency Treatment Revenue in Global Market (2017-2022)
  7.3.5 Horizo??n Pharma Key News
7.4 Medicis Pharmaceutical
  7.4.1 Medicis Pharmaceutical Corporate Summary
  7.4.2 Medicis Pharmaceutical Business Overview
  7.4.3 Medicis Pharmaceutical Arginase Deficiency Treatment Major Product Offerings
  7.4.4 Medicis Pharmaceutical Arginase Deficiency Treatment Revenue in Global Market (2017-2022)
  7.4.5 Medicis Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Arginase Deficiency Treatment Market Opportunities & Trends in Global Market
Table 2. Arginase Deficiency Treatment Market Drivers in Global Market
Table 3. Arginase Deficiency Treatment Market Restraints in Global Market
Table 4. Key Players of Arginase Deficiency Treatment in Global Market
Table 5. Top Arginase Deficiency Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Arginase Deficiency Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Arginase Deficiency Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Arginase Deficiency Treatment Product Type
Table 9. List of Global Tier 1 Arginase Deficiency Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Arginase Deficiency Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Arginase Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Arginase Deficiency Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Arginase Deficiency Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Arginase Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Arginase Deficiency Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Arginase Deficiency Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Arginase Deficiency Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Arginase Deficiency Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Arginase Deficiency Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Arginase Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Arginase Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Arginase Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Arginase Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Arginase Deficiency Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Helsinn Healthcare Corporate Summary
Table 31. Helsinn Healthcare Arginase Deficiency Treatment Product Offerings
Table 32. Helsinn Healthcare Arginase Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Pharmaceuticals Corporate Summary
Table 34. Novartis Pharmaceuticals Arginase Deficiency Treatment Product Offerings
Table 35. Novartis Pharmaceuticals Arginase Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Horizo??n Pharma Corporate Summary
Table 37. Horizo??n Pharma Arginase Deficiency Treatment Product Offerings
Table 38. Horizo??n Pharma Arginase Deficiency Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Medicis Pharmaceutical Corporate Summary
Table 40. Medicis Pharmaceutical Arginase Deficiency Treatment Product Offerings
Table 41. Medicis Pharmaceutical Arginase Deficiency Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Arginase Deficiency Treatment Segment by Type in 2021
Figure 2. Arginase Deficiency Treatment Segment by Application in 2021
Figure 3. Global Arginase Deficiency Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Arginase Deficiency Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Arginase Deficiency Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Arginase Deficiency Treatment Revenue in 2021
Figure 8. By Type - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 12. US Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 24. China Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Arginase Deficiency Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Arginase Deficiency Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Helsinn Healthcare Arginase Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Pharmaceuticals Arginase Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Horizo??n Pharma Arginase Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medicis Pharmaceutical Arginase Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)